Bai-li Chen
Impact in
- Genetics top 1%
- Inflammatory Bowel Disease
- Mesenchymal stem cell research
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Genetics 82
- Inflammatory Bowel Disease 81
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Yao He (60 shared papers)Ren Mao (40 shared papers)Shenghong Zhang (41 shared papers)Minhu Chen (39 shared papers)Yun Qiu (35 shared papers)Minhu Chen (30 shared papers)Zhirong Zeng (41 shared papers)Xiang Gao (13 shared papers)
- Journals
- Inflammatory Bowel Diseases (9 papers)Therapeutic Advances in Gastroenterology (9 papers)Gastroenterology (7 papers)Clinical and Translational Gastroenterology (4 papers)Journal of Crohn s and Colitis (4 papers)
- Partner nations
- ChinaIsraelUnited States
In The Last Decade
Bai-li Chen
102 papers receiving 2.5k citations
Bai-li Chen's Hit Papers
Peers
Comparison fields: 5 of 117
- Genetics 1.5k
- Pharmacology 84
- Periodontics 54
- Gastroenterology 57
- Genetics 61
Countries citing papers authored by Bai-li Chen
This map shows the geographic impact of Bai-li Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bai-li Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bai-li Chen more than expected).
Fields of papers citing papers by Bai-li Chen
This network shows the impact of papers produced by Bai-li Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bai-li Chen. The network helps show where Bai-li Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bai-li Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 247 | |
| 2 | 2017 | 156 | |
| 3 | 2017 | 95 | |
| 4 | 1989 | 83 | |
| 5 | 2018 | 76 | |
| 6 | 2023 | 76 | |
| 7 | 2023 | 71 | |
| 8 | Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study Hit paper breakdown → | 2024 | 71 |
| 9 | 2016 | 62 | |
| 10 | Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies Hit paper breakdown → | 2024 | 58 |
| 11 | 1995 | 57 | |
| 12 | 2016 | 56 | |
| 13 | 2020 | 56 | |
| 14 | 2016 | 51 | |
| 15 | 2016 | 51 | |
| 16 | 2019 | 48 | |
| 17 | 2017 | 47 | |
| 18 | 2022 | 43 | |
| 19 | 2022 | 42 | |
| 20 | 2012 | 40 |
About Bai-li Chen
Bai-li Chen is a scholar working on Genetics, Pharmacology, Gastroenterology, Surgery and Genetics, having authored 107 papers that have together received 2.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (81 papers), Pharmacogenetics and Drug Metabolism (4 papers), Remote Sensing in Agriculture (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Ocular Diseases and Behçet’s Syndrome (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Diagnosis and treatment of tuberculosis (2 papers) and Ultrasound Imaging and Elastography (2 papers). The work is most often cited by research in Genetics (1.5k citations), Pharmacology (84 citations), Periodontics (54 citations), Gastroenterology (57 citations) and Genetics (61 citations). Bai-li Chen has collaborated with scholars based in China, Israel and United States. Frequent co-authors include Yao He, Ren Mao, Shenghong Zhang, Minhu Chen, Yun Qiu, Minhu Chen, Zhirong Zeng, Xiang Gao, Shomron Ben‐Horin and P. Hu. Their work appears in journals such as Inflammatory Bowel Diseases, Therapeutic Advances in Gastroenterology, Gastroenterology, Clinical and Translational Gastroenterology and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.